These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1003 related items for PubMed ID: 16989624

  • 1. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M.
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [Abstract] [Full Text] [Related]

  • 2. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R, McElhaney J, Pedalino B, Levin M.
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [Abstract] [Full Text] [Related]

  • 3. Emerging drugs for varicella-zoster virus infections.
    Andrei G, Snoeck R.
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K, Weinberg JM.
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [Abstract] [Full Text] [Related]

  • 6. Zoster vaccine: current status and future prospects.
    Oxman MN.
    Clin Infect Dis; 2010 Jul 15; 51(2):197-213. PubMed ID: 20550454
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y.
    Vaccine; 2008 Nov 25; 26(50):6487-90. PubMed ID: 18694794
    [Abstract] [Full Text] [Related]

  • 10. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G.
    Expert Rev Vaccines; 2010 Mar 25; 9(3 Suppl):31-5. PubMed ID: 20192716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I, Santa-Olalla P, Lévy-Bruhl D.
    Rev Epidemiol Sante Publique; 2008 Oct 25; 56(5):323-31. PubMed ID: 18951741
    [Abstract] [Full Text] [Related]

  • 16. Zoster vaccine live.
    Kockler DR, McCarthy MW.
    Pharmacotherapy; 2007 Jul 25; 27(7):1013-9. PubMed ID: 17594207
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM, Brisson M, Levin MJ.
    Vaccine; 2007 Nov 28; 25(49):8326-37. PubMed ID: 17980938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.